MAI Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.3M Buy
335,023
+11,532
+4% +$1.33M 0.23% 95
2025
Q4
$34.1M Buy
323,491
+32,752
+11% +$3.07M 0.2% 108
2025
Q3
$24.4M Buy
290,739
+38,358
+15% +$3.16M 0.15% 128
2025
Q2
$20M Buy
252,381
+79,506
+46% +$6.32M 0.14% 138
2025
Q1
$15.5M Sell
172,875
-7,478
-4% -$698K 0.12% 162
2024
Q4
$17.9M Buy
180,353
+15,440
+9% +$1.59M 0.13% 139
2024
Q3
$18.7M Sell
164,913
-17,494
-10% -$2.08M 0.18% 104
2024
Q2
$22.6M Buy
182,407
+1,666
+0.9% +$215K 0.22% 86
2024
Q1
$23.8M Buy
180,741
+25,836
+17% +$3.18M 0.25% 89
2023
Q4
$16.9M Buy
154,905
+536
+0.3% +$55.6K 0.22% 91
2023
Q3
$15.9M Sell
154,369
-948
-0.6% -$102K 0.24% 86
2023
Q2
$17.9M Buy
155,317
+2,363
+2% +$268K 0.26% 79
2023
Q1
$16.3M Buy
152,954
+1,148
+0.8% +$124K 0.26% 90
2022
Q4
$16.8M Sell
151,806
-5,368
-3% -$549K 0.28% 81
2022
Q3
$13.5M Buy
157,174
+26,249
+20% +$2.34M 0.25% 93
2022
Q2
$11.9M Sell
130,925
-1,060
-0.8% -$94K 0.23% 94
2022
Q1
$10.8M Sell
131,985
-8,102
-6% -$639K 0.18% 114
2021
Q4
$10.7M Buy
140,087
+231
+0.2% +$18.4K 0.17% 112
2021
Q3
$10.5M Sell
139,856
-39
-0% -$2.97K 0.2% 104
2021
Q2
$10.9M Sell
139,895
-12,877
-8% -$958K 0.22% 102
2021
Q1
$11.2M Sell
152,772
-22,362
-13% -$1.65M 0.25% 95
2020
Q4
$13.7M Sell
175,134
-605
-0.3% -$46.3K 0.34% 73
2020
Q3
$13.9M Sell
175,739
-12,690
-7% -$994K 0.4% 63
2020
Q2
$13.9M Buy
188,429
+6,135
+3% +$462K 0.44% 58
2020
Q1
$13.4M Sell
182,294
-3,292
-2% -$259K 0.55% 48
2019
Q4
$16.1M Buy
185,586
+86,492
+87% +$7.1M 0.52% 50
2019
Q3
$7.96M Buy
99,094
+4,572
+5% +$366K 0.35% 77
2019
Q2
$7.56M Buy
94,522
+4,906
+5% +$376K 0.34% 81
2019
Q1
$7.11M Buy
89,616
+670
+0.8% +$50.1K 0.36% 77
2018
Q4
$6.49M Buy
88,946
+7,738
+10% +$546K 0.38% 78
2018
Q3
$5.5M Buy
81,208
+1,027
+1% +$65.4K 0.28% 99
2018
Q2
$4.64M Buy
80,181
+1,807
+2% +$102K 0.25% 106
2018
Q1
$4.07M Buy
78,374
+4,112
+6% +$222K 0.23% 108
2017
Q4
$3.99M Buy
74,262
+13,841
+23% +$767K 0.23% 109
2017
Q3
$3.69M Buy
60,421
+1,903
+3% +$115K 0.22% 110
2017
Q2
$3.58M Buy
58,518
+1,342
+2% +$81.7K 0.23% 108
2017
Q1
$3.47M Sell
57,176
-1,975
-3% -$120K 0.23% 113
2016
Q4
$3.32M Sell
59,151
-4,249
-7% -$249K 0.24% 105
2016
Q3
$3.78M Buy
63,400
+3,057
+5% +$179K 0.28% 95
2016
Q2
$3.32M Sell
60,343
-4,595
-7% -$245K 0.26% 102
2016
Q1
$3.28M Buy
64,938
+795
+1% +$38.9K 0.25% 100
2015
Q4
$3.23M Buy
64,143
+9,852
+18% +$497K 0.25% 102
2015
Q3
$2.56M Buy
54,291
+41,742
+333% +$2.22M 0.19% 117
2015
Q2
$682K Buy
12,549
+840
+7% +$47.1K 0.04% 256
2015
Q1
$642K Buy
11,709
+1,315
+13% +$74.5K 0.04% 274
2014
Q4
$563K Sell
10,394
-210
-2% -$11.7K 0.04% 278
2014
Q3
$600K Sell
10,604
-107
-1% -$6.01K 0.06% 226
2014
Q2
$591K Sell
10,711
-3,571
-25% -$195K 0.06% 216
2014
Q1
$774K Sell
14,282
-1,179
-8% -$61.1K 0.08% 166
2013
Q4
$738K Sell
15,461
-762
-5% -$34.8K 0.08% 168
2013
Q3
$737K Buy
16,223
+586
+4% +$26.8K 0.1% 141
2013
Q2
$693K Buy
+15,637
New +$698K 0.09% 140

Other funds holding MRK

MAI Capital Management's MRK Position: Q1 2026 in Review

MAI Capital Management increased its Merck (MRK) stake by 3.6% in Q1 2026, buying an estimated $1.33M and bringing the position to 335,023 shares worth $40.3M. The position accounts for 0.23% of the portfolio, ranked #95.

MAI Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • MAI Capital Management held 335,023 shares of Merck worth $40.3M as of Q1 2026.
  • MAI Capital Management bought 11,532 Merck shares in Q1 2026, an estimated $1.33M.
  • Merck made up 0.23% of MAI Capital Management's portfolio in Q1 2026, its #95 holding.
  • MAI Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.